Re:Cognition Chicago — Chicago, Illinois

Re:Cognition Chicago is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Re:Cognition Chicago has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Early Alzheimers Disease.

Sponsors: Annovis Bio Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Re:Cognition Chicago?

Re:Cognition Chicago has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Re:Cognition Chicago conducted?

Re:Cognition Chicago has 1 clinical trials on record, with 1 currently active. Their work covers Early Alzheimers Disease.

Is Re:Cognition Chicago accredited by Crixeo Health?

Re:Cognition Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Re:Cognition Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.